PPTA Launches New Educational Website on Donating Plasma
PPTA designed this informative site in an effort to heighten publicawareness of the importance of donating plasma. DonatingPlasma.org is the onlyindustry-wide web site that seeks to explain and clarify the plasma donationprocess.
Plasma, the largest blood component, is the starting material for awide-range of life-saving medicines used to treat life-threatening, rare,chronic, and often genetic diseases and disorders such as hemophilia, primaryimmunodeficiencies, alpha-1 antitrypsin deficiency and neurological andautoimmune disorders. In addition, plasma protein therapies are used to treatmedical conditions such as shock, trauma and burns.
"A major goal of PPTA is to provide information to potential and currentplasma donors that stresses the need for their donation, which is critical inhelping to save countless lives," said PPTA President Jan M. Bult.
The site will contain up-to-the minute information about plasma donation,including donor eligibility and health, frequently asked questions, and thetime and commitment required to donate plasma," Bult said. "We hope the sitewill be a resource for those interested in donating plasma and who want tolearn more about the patients who are helped everyday by someone who givesplasma. With hundreds of thousands of people throughout the world depending onplasma-derived therapies, this new site should be valuable to those who arecurious about ways in which they can become an essential part of savingsomeone's life."
DonatingPlasma.org offers information regarding the diseases and disorderstreated with plasma protein therapies, differences in blood and plasmacollection, video segments offering real-life interviews with patients, plasmadonors and physicians, and links to patient group organizations and otheronline resources.
To view the new website, please go to http://www.DonatingPlasma.org. Formore information please contact Kara Flynn at (443) 458-4669 or Kym H.Kilbourne at (443) 458-4682.
ABOUT PPTA: The Plasma Protein Therapeutics Association (PPTA) is thetrade association and standard setting organization for the world's majorproducers of plasma-derived and recombinant analog therapies (collectively,"plasma therapies"). These therapies are used by more than 1 million peopleworldwide each year to treat a variety of diseases and serious medicalconditions. PPTA members produce over 80 percent of the plasma therapies forthe United States market and more than 60 percent worldwide. Some of thecritical therapies produced by PPTA members include: blood clotting factorsfor people with hemophilia, intravenous immune globulin used to preventinfections in people with immune deficiencies and other serious conditions,and alpha-1 proteinase inhibitor used to treat people with alpha-1-antitrypsindeficiency, also known as genetic emphysema.
SOURCE Plasma Protein Therapeutics Association
You May Also Like